David A. Siegel Axonics, Inc. Transaction History

Two Sigma Advisers, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $4.54 Million - $5.7 Million	-94,600 Reduced 40.95%	136,400 $6.88 Million
Q1 2023 May 15, 2023	SELL	$52.6 - $67.34 $1.13 Million - $1.45 Million	-21,500 Reduced 8.51%	231,000 $12.6 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $5.79 Million - $7.45 Million	97,200 Added 62.59%	252,500 $15.8 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $8.42 Million - $11.3 Million	145,200 Added 1437.62%	155,300 $10.9 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $114,550 - $186,818	2,900 Added 40.28%	10,100 $572,000
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $314,928 - $451,872	7,200 New	7,200 $451,000
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $213,156 - $283,176	-3,600 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $1.91 Million - $2.49 Million	-37,200 Reduced 91.18%	3,600 $228,000
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $2 Million - $2.44 Million	40,800 New	40,800 $2.44 Million

233

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.